Linked kdm5a jmj domain bound to the inhibitor n44 i.e. 3-((2-(pyridin-2-yl)-6-(4-(vinylsulfonyl)-1,4-diazepan-1-yl)pyrimidin-4-yl)amino)propanoic acid Deposition Author(s): Cheng, X. , Horton, J.R.
Date: 2018-06-10 Method: X-RAY DIFFRACTION Resolution: 1.587 Å Organism(s): Homo Sapiens Sequences Data: 6DQ6_A
Linked kdm5a jmj domain bound to the potential hydrolysis product of inhibitor n45 i.e. 3-((6-(4-(2-cyano-3-methylbut-2-enoyl)-1,4-diazepan-1-yl)-2-(pyridin-2-yl)pyrimidin-4-yl)amino)propanoic acid Deposition Author(s): Cheng, X. , Horton, J.R.
Date: 2018-06-10 Method: X-RAY DIFFRACTION Resolution: 1.852 Å Organism(s): Homo Sapiens Sequences Data: 6DQ7_A
Linked kdm5a jmj domain bound to the inhibitor n49 i.e. 2-((2-chlorophenyl)(2-(1-methylpyrrolidin-2-yl)ethoxy)methyl)thieno[3,2-b]pyridine-7-carboxylic acid Deposition Author(s): Cheng, X. , Horton, J.R.
Date: 2018-06-10 Method: X-RAY DIFFRACTION Resolution: 1.46 Å Organism(s): Homo Sapiens Sequences Data: 6DQ8_A
Linked kdm5a jmj domain bound to the covalent inhibitor n69 i.e. [2-((3-acrylamidophenyl)(2-(piperidin-1-yl)ethoxy)methyl)thieno[3,2-b]pyridine-7-carboxylic acid] Deposition Author(s): Cheng, X. , Horton, J.R.
Date: 2018-06-10 Method: X-RAY DIFFRACTION Resolution: 1.748 Å Organism(s): Homo Sapiens Sequences Data: 6DQ9_A
Linked kdm5a jmj domain bound to inhibitor n70 i.e.[2-((3-aminophenyl)(2-(piperidin-1-yl)ethoxy)methyl)thieno[3,2-b]pyridine-7-carboxylic acid] Deposition Author(s): Cheng, X. , Horton, J.R.
Date: 2018-06-10 Method: X-RAY DIFFRACTION Resolution: 1.888 Å Organism(s): Homo Sapiens Sequences Data: 6DQA_A
Linked kdm5a jmj domain forming covalent bond to inhibitor n71 i.e. 2-((3-(4-(dimethylamino)but-2-enamido)phenyl)(2-(piperidin-1-yl)ethoxy)methyl)thieno[3,2-b]pyridine-7-carboxylic acid Deposition Author(s): Cheng, X. , Horton, J.R.
Date: 2018-06-10 Method: X-RAY DIFFRACTION Resolution: 1.791 Å Organism(s): Homo Sapiens Sequences Data: 6DQB_A
Linked kdm5a jmj domain bound to the inhibitor n50 i.e. 2-(4-((2-(dimethylamino)ethyl)(ethyl)carbamoyl)-5-(4-methoxyphenyl)-1h-pyrazol-1-yl)isonicotinic acid Deposition Author(s): Cheng, X. , Horton, J.R.
Date: 2018-06-10 Method: X-RAY DIFFRACTION Resolution: 1.755 Å Organism(s): Homo Sapiens Sequences Data: 6DQC_A
Linked kdm5a jmj domain bound to the inhibitor n53 i.e. 2-(5-([1,1'-biphenyl]-3-yl)-4-(1-(2-(piperidin-1-yl)ethoxy)ethyl)-1h-pyrazol-1-yl)isonicotinic acid Deposition Author(s): Cheng, X. , Horton, J.R.
Date: 2018-06-10 Method: X-RAY DIFFRACTION Resolution: 1.987 Å Organism(s): Homo Sapiens Sequences Data: 6DQD_A
Linked kdm5a jmj domain bound to the inhibitor n67 i.e. 2-(5-phenyl-4-(phenyl(2-(piperidin-1-yl)ethoxy)methyl)-1h-pyrazol-1-yl)isonicotinic acid Deposition Author(s): Cheng, X. , Horton, J.R.
Date: 2018-06-10 Method: X-RAY DIFFRACTION Resolution: 1.689 Å Organism(s): Homo Sapiens Sequences Data: 6DQE_A
Linked kdm5a jmj domain bound to the inhibitor n68 i.e. 2-(1-(2-(piperidin-1-yl)ethyl)-1h-benzo[d]imidazol-2-yl)thieno[3,2-b]pyridine-7-carboxylic acid Deposition Author(s): Cheng, X. , Horton, J.R.
Date: 2018-06-10 Method: X-RAY DIFFRACTION Resolution: 1.688 Å Organism(s): Homo Sapiens Sequences Data: 6DQF_A